Skip to content
OpenCapital
Get started

Xenetic Biosciences XBIO Q1 2026 Annual earnings

Reported May 12, 2026 · After market close

Revenue$806.9K
EPS-$0.20

Next report

Aug 7, 2026 (In 1 week)

Versus estimates

Revenue

Q1 2026$806.9K
Q4 2025$766.3KBeat by $76.3KQ3 2025$1.0MBeat by $397.0KQ2 2025$589.9KBeat by $110.9KQ1 2025$593.3KBeat by $77.3KQ4 2024$648.8K

Diluted EPS

Q1 2026-$0.20
Q4 2025-$0.22Beat by $0.30Q3 2025-$0.33Beat by $0.16Q2 2025-$0.45Beat by $0.19Q1 2025-$0.59Beat by $0.13Q4 2024-$0.68

Ask the moment Xenetic Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Xenetic Biosciences report Q1 2026 earnings?
Xenetic Biosciences (XBIO) reported Q1 2026 earnings on May 12, 2026 after market close.
What were Xenetic Biosciences's Q1 2026 revenue and EPS?
Xenetic Biosciences reported revenue of $806.9K and eps of $-0.20 for Q1 2026.
How did Xenetic Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 36.0% from $593.3K a year earlier and eps grew 66.1% from $-0.59.
Where can I find Xenetic Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001683168-26-003766) and the 10-K/A periodic report (0001683168-26-003207) directly on SEC EDGAR. The filing index links above go to sec.gov.